Buy Recommendation Issued On MAZE By H.C. Wainwright
Source: KlickAnalytics
2025-12-03 09:15:04 ET
Historical Analyst Recommendations
Latest 10 recommendations
Maze Therapeutics Inc.
NASDAQ: MAZE
MAZE Trading
8.81% G/L:
$48.56 Last:
269,438 Volume:
$46.29 Open:
MAZE Latest News
February 25, 2026 07:00:00 am
Maze Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
February 18, 2026 03:50:42 pm
Marc Andreessen's a16z Invests $465 Million in Navan's Corporate Spending Platform, According to Recent SEC Filing
February 16, 2026 01:55:14 am
Maze Therapeutics Chief Medical Officer Sells 15K Shares As Company's Stock Continues to Surge
February 04, 2026 07:00:00 am
Maze Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
MAZE Stock Data
$2,327,537,506
23,771,005
0.82%
31
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
